Empagliflozin (Addendum to Commission A14-26) [Internet].

On 22 December 2014, the Federal Joint Committee (G-BA) commissioned the Institute for Quality and Efficiency in Health Care (IQWiG) to conduct a supplementary assessment for Commission A14-26 (Empagliflozin – Benefit assessment according to §35a Social Code Book (SGB) V).

http://ift.tt/2rveLRY